tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AUTL Stock Latest News

Autolus Therapeutics appoints WIll as Chief Development Officer
The FlyAutolus Therapeutics appoints WIll as Chief Development Officer
2d ago
AUTL
Autolus presents clinical data on TB-guided dosing strategy at SOHO meetin
PremiumThe Fly
Autolus presents clinical data on TB-guided dosing strategy at SOHO meetin
25d ago
AUTL
Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024
PremiumPress Releases
Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024
25d ago
AUTL
Autolus Therapeutics Q2 Results and Corporate Presentation Update
PremiumCompany Announcements
Autolus Therapeutics Q2 Results and Corporate Presentation Update
1M ago
8K
AUTL
Autolus Therapeutics reports Q2 EPS (22c), consensus (19c)
PremiumThe Fly
Autolus Therapeutics reports Q2 EPS (22c), consensus (19c)
1M ago
AUTL
Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates
PremiumPress ReleasesAutolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates
1M ago
AUTL
Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
Premium
Press Releases
Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
2M ago
AUTL
Autolus Therapeutics to present three clinical data updates on obe-cel
Premium
The Fly
Autolus Therapeutics to present three clinical data updates on obe-cel
3M ago
AUTL
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
PremiumPress Releases
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
3M ago
AUTL
Autolus Therapeutics Shares Key FELIX Study Updates
PremiumCompany Announcements
Autolus Therapeutics Shares Key FELIX Study Updates
4M ago
8K
AUTL
Autolus Therapeutics presents longer-term follow-up data analysis of FELIX study
PremiumThe Fly
Autolus Therapeutics presents longer-term follow-up data analysis of FELIX study
4M ago
AUTL
Autolus Therapeutics Shares Q1 Results and Corporate Update
PremiumCompany Announcements
Autolus Therapeutics Shares Q1 Results and Corporate Update
4M ago
8K
AUTL
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
PremiumPress ReleasesAutolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
4M ago
AUTL
Options Volatility and Implied Earnings Moves Today, May 17, 2024
Premium
Market News
Options Volatility and Implied Earnings Moves Today, May 17, 2024
4M ago
CAN
RBC
Autolus Therapeutics reports Q1 EPS (24c), consensus (5c)
Premium
The Fly
Autolus Therapeutics reports Q1 EPS (24c), consensus (5c)
4M ago
AUTL
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
PremiumPress Releases
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
4M ago
AUTL
Autolus files to delay quarterly report, cancels earnings call
PremiumThe Fly
Autolus files to delay quarterly report, cancels earnings call
4M ago
AUTL
Autolus Therapeutics Announces Q1 2024 Financial Update
PremiumCompany Announcements
Autolus Therapeutics Announces Q1 2024 Financial Update
4M ago
8K
AUTL
Autolus Therapeutics announces delay to Q1 earnings release, conference call
PremiumThe Fly
Autolus Therapeutics announces delay to Q1 earnings release, conference call
4M ago
AUTL
AUTL Earnings this Week: How Will it Perform?
PremiumPre-EarningsAUTL Earnings this Week: How Will it Perform?
4M ago
AUTL
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
Premium
Press Releases
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
5M ago
AUTL
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
Premium
Press Releases
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
5M ago
AUTL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >